Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Locations were updated with many new sites across the US, Australia, Canada, and Europe, and numerous sites were removed. The entry also shows a page revision tag, Revision: v3.3.3.
    Difference
    3%
    Check dated 2025-12-23T17:21:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed. Updated the revision tag to v3.3.2.
    Difference
    0.3%
    Check dated 2025-11-24T20:58:10.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The generic government funding operating-status notice was removed, with no changes to the study details or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:13:10.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    No additions or deletions affecting the study details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:53:41.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:39:59.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.
    Difference
    0.3%
    Check dated 2025-09-28T11:14:42.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.